↓ Skip to main content

Rev-erb beta regulates the Srebp-1c promoter and mRNA expression in skeletal muscle cells

Overview of attention for article published in Biochemical & Biophysical Research Communications, August 2009
Altmetric Badge

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Rev-erb beta regulates the Srebp-1c promoter and mRNA expression in skeletal muscle cells
Published in
Biochemical & Biophysical Research Communications, August 2009
DOI 10.1016/j.bbrc.2009.08.045
Pubmed ID
Authors

Sathiya N. Ramakrishnan, Patrick Lau, Lisa M. Crowther, Mark E. Cleasby, Susan Millard, Gary M. Leong, Gregory J. Cooney, George E.O. Muscat

Abstract

The nuclear hormone receptor, Rev-erb beta operates as a transcriptional silencer. We previously demonstrated that exogenous expression of Rev-erb betaDeltaE in skeletal muscle cells increased Srebp-1c mRNA expression. We validated these in vitro observations by injection of an expression vector driving Rev-erb betaDeltaE expression into mouse tibialis muscle that resulted in increased Srebp-1c mRNA expression. Paradoxically, Rev-erb beta siRNA expression in skeletal muscle cells repressed Srebp-1c expression, and indicated that Rev-erb beta expression was necessary for Srebp-1c expression. ChIP analysis demonstrated that Rev-erb beta was recruited to the Srebp-1c promoter. Moreover, Rev-erb beta trans-activated the Srebp-1c promoter, in contrast, Rev-erb beta efficiently repressed the Rev-erb alpha promoter, a previously characterized target gene. Finally, treatment with the Rev-erb agonist (hemin) (i) increased the trans-activation of the Srebp-1c promoter by Rev-erb beta; and (ii) increased Rev-erb beta and Srebp-1c mRNA expression. These data suggest that Rev-erb beta has the potential to activate gene expression, and is a positive regulator of Srebp-1c, a regulator of lipogenesis.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Sweden 1 3%
France 1 3%
Australia 1 3%
Unknown 27 90%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 27%
Student > Ph. D. Student 7 23%
Professor > Associate Professor 3 10%
Professor 2 7%
Student > Master 2 7%
Other 2 7%
Unknown 6 20%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 11 37%
Agricultural and Biological Sciences 10 33%
Medicine and Dentistry 2 7%
Immunology and Microbiology 1 3%
Unknown 6 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 October 2010.
All research outputs
#8,675,798
of 25,711,518 outputs
Outputs from Biochemical & Biophysical Research Communications
#7,682
of 26,748 outputs
Outputs of similar age
#42,860
of 124,781 outputs
Outputs of similar age from Biochemical & Biophysical Research Communications
#44
of 112 outputs
Altmetric has tracked 25,711,518 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 26,748 research outputs from this source. They receive a mean Attention Score of 4.5. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 124,781 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 112 others from the same source and published within six weeks on either side of this one. This one is in the 6th percentile – i.e., 6% of its contemporaries scored the same or lower than it.